Compare Elder Pharma with Panacea Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs PANACEA BIOTECH - Comparison Results

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA PANACEA BIOTECH ELDER PHARMA/
PANACEA BIOTECH
 
P/E (TTM) x -0.2 11.7 - View Chart
P/BV x 0.1 2.8 3.6% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 ELDER PHARMA   PANACEA BIOTECH
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
PANACEA BIOTECH
Mar-18
ELDER PHARMA/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs380364 104.4%   
Low Rs188129 145.6%   
Sales per share (Unadj.) Rs491.296.8 507.5%  
Earnings per share (Unadj.) Rs-3.2-12.4 25.6%  
Cash flow per share (Unadj.) Rs14.4-2.9 -505.2%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs376.550.4 747.1%  
Shares outstanding (eoy) m20.5461.25 33.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.62.5 22.7%   
Avg P/E ratio x-89.3-19.9 449.2%  
P/CF ratio (eoy) x19.7-86.4 -22.8%  
Price / Book Value ratio x0.84.9 15.4%  
Dividend payout %00-   
Avg Mkt Cap Rs m5,83315,101 38.6%   
No. of employees `000NA2.5 0.0%   
Total wages/salary Rs m2,1791,516 143.7%   
Avg. sales/employee Rs ThNM2,401.9-  
Avg. wages/employee Rs ThNM614.2-  
Avg. net profit/employee Rs ThNM-307.9-  
INCOME DATA
Net Sales Rs m10,0895,928 170.2%  
Other income Rs m25782 311.8%   
Total revenues Rs m10,3466,010 172.1%   
Gross profit Rs m-792845 -93.7%  
Depreciation Rs m361585 61.7%   
Interest Rs m2,7561,006 274.0%   
Profit before tax Rs m-3,653-664 550.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m02 0.0%   
Extraordinary Inc (Exp) Rs m3,7130-   
Tax Rs m12599 126.9%   
Profit after tax Rs m-65-760 8.6%  
Gross profit margin %-7.814.3 -55.0%  
Effective tax rate %-3.4-14.9 23.1%   
Net profit margin %-0.6-12.8 5.1%  
BALANCE SHEET DATA
Current assets Rs m9,2405,603 164.9%   
Current liabilities Rs m9,9986,910 144.7%   
Net working cap to sales %-7.5-22.0 34.1%  
Current ratio x0.90.8 114.0%  
Inventory Days Days46206 22.5%  
Debtors Days Days6084 71.6%  
Net fixed assets Rs m10,1249,941 101.8%   
Share capital Rs m20661 335.6%   
"Free" reserves Rs m5,5823,026 184.5%   
Net worth Rs m7,7343,087 250.5%   
Long term debt Rs m4,8895,707 85.7%   
Total assets Rs m22,88216,076 142.3%  
Interest coverage x-0.30.3 -95.6%   
Debt to equity ratio x0.61.8 34.2%  
Sales to assets ratio x0.40.4 119.6%   
Return on assets %11.81.5 769.1%  
Return on equity %-0.8-24.6 3.4%  
Return on capital %22.33.9 569.7%  
Exports to sales %3.024.0 12.6%   
Imports to sales %0.417.5 2.4%   
Exports (fob) Rs m3071,424 21.5%   
Imports (cif) Rs m431,040 4.1%   
Fx inflow Rs m3071,600 19.2%   
Fx outflow Rs m1251,131 11.1%   
Net fx Rs m181469 38.7%   
CASH FLOW
From Operations Rs m11,7541,180 995.9%  
From Investments Rs m-561553 -101.4%  
From Financial Activity Rs m-6,762-1,644 411.4%  
Net Cashflow Rs m4,43290 4,940.6%  

Share Holding

Indian Promoters % 39.6 74.5 53.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.5 0.6 1,250.0%  
FIIs % 16.8 1.3 1,292.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 23.6 153.0%  
Shareholders   16,479 10,259 160.6%  
Pledged promoter(s) holding % 77.6 35.1 221.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   ABBOTT INDIA  JUBILANT LIFE SCIENCES  DIVIS LABORATORIES  PIRAMAL ENTERPRISES  NATCO PHARMA  

Compare ELDER PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Green; Bajaj Finance and ICICI Bank Top Gainers(12:30 pm)

Stock markets in India are presently trading on a positive note. The BSE Sensex is trading up by 90 points and the NSE Nifty is trading up by 35 points.

Related Views on News

PANACEA BIOTECH 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of PANACEA BIOTECH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PANACEA BIOTECH. Also includes updates on the valuation of PANACEA BIOTECH.

PANACEA BIOTECH Announces Quarterly Results (3QFY19); Net Profit Down 137.1% (Quarterly Result Update)

Feb 22, 2019 | Updated on Feb 22, 2019

For the quarter ended December 2018, PANACEA BIOTECH has posted a net profit of Rs 230 m (down 137.1% YoY). Sales on the other hand came in at Rs 1 bn (down 25.2% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

PANACEA BIOTECH Announces Quarterly Results (2QFY19); Net Profit Down 1631.6% (Quarterly Result Update)

Nov 27, 2018 | Updated on Nov 27, 2018

For the quarter ended September 2018, PANACEA BIOTECH has posted a net profit of Rs 975 m (down 1631.6% YoY). Sales on the other hand came in at Rs 1 bn (down 22.3% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

PANACEA BIOTECH Announces Quarterly Results (4QFY18); Net Profit Down 66.5% (Quarterly Result Update)

Jun 20, 2018 | Updated on Jun 20, 2018

For the quarter ended March 2018, PANACEA BIOTECH has posted a net profit of Rs 86 m (down 66.5% YoY). Sales on the other hand came in at Rs 2 bn (up 0.3% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Rebound Riches Could be Yours With These Stocks(Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA 5-YR ANALYSIS

COMPARE ELDER PHARMA WITH

MARKET STATS